Inovio Pharmaceuticals Inc (INO)

[ImaPseudonym]

Now I see the problem. You are looking for the company's progress by looking at *old* material. If you want to see where they are now, you should look at *current* status.

Start here:
http://www.inovio.com/products/pipeline/

I count 7 studies in human subjects.

Yes, in addition to those there is also a *lot* of preclinical research going on. And researchers need to publish their results in peer-reviewed journals (it is part of their job, and one of the only things their deans and provosts care about). INO doeesn't even PR all of the peer-reviewed preclinical stuff there is so much of it.

Maybe you could explain why having a ton of pre-clinical work going on in the background in addition to the several products making their way through clinical stages is supposed to be a bad thing.

Remember that a single pre-clinical MAB just merited a $500 mil. buyout.

You might also want to review the recent guidelines for Breakthrough Designation which has a pathway for a new product based on a single phase 1 study alone.